13 January 2026
THG PLC
Fourth quarter trading statement for the period ended 31 December 2025
Record H2 revenue performance, c.14% ahead of the top end of guidance
THG Beauty outperformance drives Q4 Group revenue growth of +7.0%, strongest YTD
High confidence in THG Beauty and THG Nutrition trading momentum into Q1 2026, following c.8% revenue growth over November and December
Outlook and guidance
o THG Beauty delivered +5.5% H2 revenue growth, well ahead of +1.0% to +3.0% guidance; and
o THG Nutrition delivered +9.2% H2 revenue growth (+12.7% excluding Asia), broadly in-line with the +10.0% to +12.0% guidance.
Q4 2025 Group trading performance
|
|
|
Q4 2025 |
|
|
FY 2025 |
|
|
£m |
Q4 2025 |
YoY Growth |
FY 2025 |
YoY Growth |
Continuing CCY |
|
|
THG Beauty |
370.2 |
+2.2% |
+6.4% |
1,108.3 |
-5.4% |
+0.3% |
|
THG Nutrition |
157.2 |
+8.1% |
+8.5% |
607.7 |
+4.7% |
+6.2% |
|
Total revenue |
527.4 |
+3.9% |
+7.0% |
1,716.0 |
-2.0% |
+2.3% |
All comparative figures are continuing CCY unless otherwise stated, all numbers and tables subject to rounding. FY 2024 has been restated to reflect the demerger of THG Ingenuity.
THG Beauty Q4 2025 highlights
THG Nutrition Q4 2025 highlights
Matthew Moulding, CEO of THG, commented:
"We finished 2025 on a high with our best quarter of the year thanks to a strong November and December period. In THG Beauty, our strategy to focus on core categories and territories is delivering clear results, with Lookfantastic UK achieving exceptional growth. We continue to accelerate our digital leadership, prioritising high-margin prestige brands and enhancing personalisation by increased use of AI and virtual tools.
"THG Nutrition has delivered its fourth consecutive quarter of revenue growth, driven by the strength of the Myprotein brand and our successful offline global expansion strategy which has seen us exceed our distribution targets across retail and licencing.
"We enter the new year with strong trading momentum and a clear focus on continuing to deliver quality, value and newness for our customers."
Analyst and Institutional investor conference call
THG will today host a conference call and webcast for analysts and investors at 9.00am (UK time) via the following link:
https://stream.brrmedia.co.uk/broadcast/695cfa5b87ddc40013b867a5
To ask questions, you must dial in via conference line using the below details:
For further information please contact:
|
Investor enquiries - THG PLC |
|
|
Kate Grimoldby, Director of Investor Relations and Strategic Projects |
|
|
Media enquiries: |
|
|
Sodali & Co - Financial PR adviser |
Tel: +44 (0) 20 7100 6451 |
|
Russ Lynch/Sam Austrums/Louisa Henry |
|
|
THG PLC
|
media-enquiries@thg.com |
|
|
|
Notes to Editors
THG PLC is a global e-commerce group and brand owner headquartered in Manchester, UK, which operates through two leading consumer businesses: THG Beauty and THG Nutrition.
THG Beauty operates prominent online platforms including Lookfantastic, Dermstore and Cult Beauty, offering a valued route to market for over 1,000 third-party brands, alongside a specialist portfolio of owned brands.
THG Nutrition, led by Myprotein, the world's largest online sports nutrition brand, spans multiple health and wellness categories, delivering its products both directly to consumers and through strategic offline partnerships worldwide.
Cautionary Statement
Certain statements included within this announcement may constitute "forward-looking statements" in respect of the group's operations, performance, prospects and/or financial condition. Forward-looking statements are sometimes, but not always, identified by their use of a date in the future or such words and words of similar meaning as "anticipates", "aims", "due", "could", "may", "will", "should", "expects", "believes", "intends", "plans", "potential", "targets", "goal" or "estimates". By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions and actual results or events may differ materially from those expressed or implied by those statements. Accordingly, no assurance can be given that any particular expectation will be met and reliance should not be placed on any forward-looking statement. Additionally, forward-looking statements regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. No responsibility or obligation is accepted to update or revise any forward-looking statement resulting from new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast. This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any shares or other securities in the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares or other securities of the Company. Past performance cannot be relied upon as a guide to future performance and persons needing advice should consult an independent financial adviser. Statements in this announcement reflect the knowledge and information available at the time of its preparation.
Appendix
Quarterly continuing constant currency revenue growth rate
|
|
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
FY 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
H1 2025 |
H2 2025 |
FY 2025 |
|
THG Beauty |
+13.6% |
+3.5% |
+3.2% |
+0.8% |
+4.6% |
-9.8% |
-2.1% |
+4.2% |
+6.4% |
-5.9% |
+5.5% |
+0.3% |
|
THG Nutrition |
-5.7% |
-9.4% |
-10.5% |
-9.4% |
-8.7% |
+0.3% |
+6.2% |
+10.0% |
+8.5% |
+3.2% |
+9.2% |
+6.2% |
|
Total revenue |
+5.5% |
-1.5% |
-2.0% |
-2.5% |
-0.4% |
-6.1% |
+0.9% |
+6.3% |
+7.0% |
-2.5% |
+6.7% |
+2.3% |
Quarterly reported growth rate
|
|
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
FY 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
H1 2025 |
H2 2025 |
FY 2025 |
|
THG Beauty |
+3.9% |
-2.5% |
-3.1% |
-8.0% |
-3.1% |
-15.3% |
-9.6% |
-1.2% |
+2.2% |
-12.4% |
+0.8% |
-5.4% |
|
THG Nutrition |
-12.2% |
-15.0% |
-14.0% |
-13.1% |
-13.6% |
-2.3% |
+4.5% |
+9.3% |
+8.1% |
+1.1% |
+8.7% |
+4.7% |
|
Total revenue |
-2.6% |
-7.3% |
-7.1% |
-9.5% |
-6.8% |
-10.6% |
-4.7% |
+2.4% |
+3.9% |
-7.6% |
+3.2% |
+2.0% |
Quarterly reported revenue
|
£m |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
FY 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
H1 2025 |
H2 2025 |
FY 2025 |
|
THG Beauty |
268.9 |
278.8 |
261.3 |
362.2 |
1,171.1 |
227.8 |
252.0 |
258.2 |
370.2 |
479.9 |
628.4 |
1,108.3 |
|
THG Nutrition |
151.3 |
149.1 |
134.5 |
145.4 |
580.3 |
147.8 |
155.8 |
147.0 |
157.2 |
303.6 |
304.2 |
607.7 |
|
Total revenue |
420.2 |
427.8 |
395.7 |
507.6 |
1,751.4 |
375.6 |
407.8 |
405.2 |
527.4 |
783.4 |
932.6 |
1,716.0 |
Ends
[[1]] Consensus dated 05.11.25 and available at https://www.thg.com/investor-relations/analyst-consensus.
[[2]] Continuing excludes discontinued categories and Claremont Ingredients, the sale of which completed on 2 September 2025.